5-107381343-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001962.3(EFNA5):c.599G>A(p.Arg200His) variant causes a missense change. The variant allele was found at a frequency of 0.000118 in 1,613,818 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00026 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 0 hom. )
Consequence
EFNA5
NM_001962.3 missense
NM_001962.3 missense
Scores
4
7
8
Clinical Significance
Conservation
PhyloP100: 6.69
Genes affected
EFNA5 (HGNC:3225): (ephrin A5) Ephrin-A5, a member of the ephrin gene family, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. The EPH and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, particularly in the nervous system. EPH receptors typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin ligands and receptors have been named by the Eph Nomenclature Committee (1997). Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are similarly divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.27941245).
BS2
High AC in GnomAd4 at 39 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFNA5 | NM_001962.3 | c.599G>A | p.Arg200His | missense_variant | 5/5 | ENST00000333274.11 | NP_001953.1 | |
EFNA5 | NM_001410773.1 | c.518G>A | p.Arg173His | missense_variant | 4/4 | NP_001397702.1 | ||
EFNA5 | XM_011543250.4 | c.545G>A | p.Arg182His | missense_variant | 5/5 | XP_011541552.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFNA5 | ENST00000333274.11 | c.599G>A | p.Arg200His | missense_variant | 5/5 | 1 | NM_001962.3 | ENSP00000328777.6 | ||
EFNA5 | ENST00000509503.1 | c.518G>A | p.Arg173His | missense_variant | 4/4 | 5 | ENSP00000426989.1 | |||
EFNA5 | ENST00000510359.1 | n.247G>A | non_coding_transcript_exon_variant | 4/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152158Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
39
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000876 AC: 22AN: 251198Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135760
GnomAD3 exomes
AF:
AC:
22
AN:
251198
Hom.:
AF XY:
AC XY:
10
AN XY:
135760
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000104 AC: 152AN: 1461660Hom.: 0 Cov.: 30 AF XY: 0.0000866 AC XY: 63AN XY: 727102
GnomAD4 exome
AF:
AC:
152
AN:
1461660
Hom.:
Cov.:
30
AF XY:
AC XY:
63
AN XY:
727102
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000256 AC: 39AN: 152158Hom.: 1 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74322
GnomAD4 genome
AF:
AC:
39
AN:
152158
Hom.:
Cov.:
32
AF XY:
AC XY:
13
AN XY:
74322
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
12
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2024 | The c.599G>A (p.R200H) alteration is located in exon 5 (coding exon 5) of the EFNA5 gene. This alteration results from a G to A substitution at nucleotide position 599, causing the arginine (R) at amino acid position 200 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Benign
.;L;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N;N
REVEL
Uncertain
Sift
Uncertain
.;D;T
Sift4G
Benign
T;T;T
Polyphen
1.0
.;D;.
Vest4
0.45, 0.61
MVP
MPC
1.9
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at